Although we could not identify the specific DUB responsible for regulating Smad4 expression, our data suggest that inhibition of DUBs might be a candidate therapeutic treatment to reduce Smad4 expression and prevent renal fibrosis in CKD. This evidence concerns the gene SMAD4 and chronic kidney disease.